Managing Compliance Programs

Managing Compliance Programs

A structured framework for building, operating, and measuring the effectiveness of healthcare compliance programs based on OIG's Seven Elements, the Federal Sentencing Guidelines, and CMS program integrity requirements.

Why This Skill Exists

OIG has published compliance program guidance for virtually every healthcare sector—hospitals, physician practices, clinical laboratories, nursing facilities, home health, DME suppliers, ambulance providers, and third-party billers. The ACA § 6401 mandated compliance programs for Medicare/Medicaid providers and suppliers, and CMS has incorporated compliance program requirements into enrollment conditions. Beyond regulatory mandate, an effective compliance program is the single most significant mitigating factor in enforcement outcomes—it can reduce Federal Sentencing Guidelines culpability scores, support good-faith defenses in FCA actions, and demonstrate the "effective compliance program" factor that OIG considers in exclusion decisions. Organizations without structured compliance programs face maximum penalties and zero mitigation credit when violations surface.

Checkpoint A — Program Assessment Intake

Intake Questions

1. Does the organization currently have a formal compliance program, and if so, when was it last comprehensively assessed?
2. What is the organization type (hospital, physician practice, post-acute, managed care, laboratory) and which OIG compliance program guidance applies?
3. Who is the designated compliance officer, and do they report directly to the CEO and governing body per OIG guidance?
4. Does the compliance officer have adequate authority, resources, staff, and budget to perform their function?
5. Is there a compliance committee, and does it include representatives from key operational areas (billing, clinical, legal, IT, HR)?
6. What risk areas have been identified in the most recent compliance work plan?
7. Has the organization conducted a compliance risk assessment in the past 12 months?
8. What is the organization's enforcement history—OIG investigations, CMS audits, qui tam actions, voluntary self-disclosures?
9. Does the organization participate in value-based payment models that create new compliance risk areas?
10. What is the annual compliance training completion rate and methodology?

Required Documents

• Current compliance plan/program description
• Compliance committee charter and meeting minutes (last 12 months)
• Compliance risk assessment (most recent)
• Code of conduct and standards of conduct
• Compliance policies and procedures manual
• Training curriculum and completion records
• Hotline/reporting mechanism data (reports received, investigated, resolved)
• Audit and monitoring work plan and completed audit reports
• Corrective action plans from prior audits
• Compliance officer job description and organizational chart showing reporting structure
• Board compliance reports (last 12 months)

Step 1 — Seven Elements Assessment

Evaluate the organization against OIG's Seven Elements of an Effective Compliance Program:

Element 1 — Written Policies, Procedures, and Standards of Conduct:

• Verify a comprehensive Code of Conduct exists, is distributed to all workforce members, and is updated regularly.
• Confirm policies address the organization's specific risk areas: billing and coding, physician arrangements, HIPAA, conflicts of interest, gifts and entertainment, government investigation response.
• Assess whether policies are accessible, written at appropriate literacy levels, and available in languages reflecting the workforce.
• Review the policy approval, revision, and version control process.

Element 2 — Compliance Program Administration (Compliance Officer and Committee):

• Verify the compliance officer is a senior-level position with direct access to the CEO and governing body.
• Confirm the compliance officer is not subordinate to the General Counsel, CFO, or other operational officers whose functions may conflict.
• Assess compliance committee composition, meeting frequency (at least quarterly), and whether minutes document substantive discussion and action items.
• Evaluate the compliance officer's authority to review all documents, interview personnel, and access relevant areas.

Element 3 — Training and Education:

• Verify annual general compliance training for all workforce members (including contractors with access to PHI or billing functions).
• Confirm specialized training for high-risk roles: coders receive coding-specific training, physicians receive documentation and ordering training, privacy officers receive HIPAA-specific training.
• Assess training effectiveness through post-training assessments, not just attendance tracking.
• Review new hire training timing (within 30 days of hire per best practice) and ongoing education frequency.

Element 4 — Effective Lines of Communication (Reporting Mechanisms):

• Verify a confidential and anonymous reporting mechanism exists (hotline, web portal, or both).
• Confirm the reporting mechanism is publicized and accessible to all workforce members, contractors, and patients.
• Assess non-retaliation policies and their enforcement—review whether any reporters have experienced adverse actions.
• Evaluate hotline metrics: number of reports, investigation timelines, resolution rates, report categories.

Element 5 — Internal Monitoring and Auditing:

• Review the annual audit work plan and verify it is risk-based (aligned with the compliance risk assessment).
• Confirm audits cover high-risk areas: claims accuracy, medical necessity documentation, physician arrangement compliance, HIPAA safeguards, excluded party screening.
• Assess audit methodology—sample sizes, statistical validity, baseline/follow-up cadence.
• Verify audit findings are tracked to resolution with documented corrective actions.

Element 6 — Enforcement Through Disciplinary Guidelines:

• Confirm disciplinary policies apply uniformly across all levels, including senior leadership and physicians.
• Verify disciplinary standards are published and workforce members acknowledge them.
• Review whether disciplinary actions have actually been imposed for compliance violations—a policy that is never enforced is evidence of an ineffective program.
• Assess whether discipline is proportionate to the violation severity and progressive in nature.

Element 7 — Response to Detected Offenses and Corrective Action:

• Verify a documented process exists for responding to compliance violations including investigation protocols, corrective action development, and root cause analysis.
• Confirm the organization evaluates voluntary self-disclosure (OIG SDP, CMS SRDP) when violations with potential overpayment are identified.
• Assess the 60-day overpayment return obligation under 42 U.S.C. § 1320a-7k(d)—identified overpayments must be returned within 60 days or reported by the date any corresponding cost report is due.
• Review whether the organization conducts post-corrective-action monitoring to verify effectiveness.

Step 2 — Compliance Risk Assessment

• Conduct or evaluate the annual compliance risk assessment using a structured methodology.
• Risk categories should include: billing and coding accuracy, physician compensation arrangements (Stark/AKS), HIPAA privacy and security, quality of care, excluded parties, conflicts of interest, government investigation preparedness, and program-specific risks (e.g., Medicaid managed care, Medicare Advantage).
• For each risk, assess inherent risk (likelihood × impact), existing controls, residual risk, and risk trend (increasing, stable, decreasing).
• Prioritize risks using a heat map or scoring matrix and align the annual audit work plan to the highest-priority residual risks.
• Document the risk assessment process, participants, data sources, and conclusions.

Step 3 — Excluded Party Screening and Credentialing Integration

• Verify the organization screens all workforce members, physicians, contractors, vendors, and downstream entities against the OIG LEIE (List of Excluded Individuals/Entities) and GSA SAM.gov at hire/contracting and monthly thereafter.
• Confirm screening covers owners and managing employees per CMS enrollment requirements.
• Document the screening process, tools used, frequency, and responsible parties.
• Establish protocols for immediate action when an exclusion match is identified—employment/contracting must cease, and overpayments attributable to the excluded individual must be calculated and returned.

Step 4 — Board and Leadership Reporting

• Verify the compliance officer provides regular reports to the governing body (at least quarterly for committees, semi-annually for the full board).
• Reports should include: compliance program activities, audit findings and corrective action status, hotline metrics and investigation outcomes, regulatory developments, risk assessment updates, and enforcement action summaries.
• Assess whether the board asks substantive questions, requests follow-up, and provides documented direction on compliance matters.
• Evaluate whether compliance is a standing agenda item at board meetings with allocated time for discussion.

Step 5 — Program Effectiveness Metrics

Establish and evaluate quantitative and qualitative measures of program effectiveness:

Checkpoint B — Program Review Validation

1. Verify all seven OIG elements are addressed with specific policies, processes, and evidence of operationalization.
2. Confirm the compliance officer has appropriate authority, independence, and resources—organizational chart reflects direct reporting to CEO and board.
3. Validate the compliance risk assessment is current, comprehensive, and drives the audit work plan.
4. Verify excluded party screening is monthly and covers all required categories.
5. Confirm the board receives substantive compliance reports and minutes document engagement.
6. Assess whether the compliance program adapts to new risks (value-based payment, telehealth, AI/ML tools) or remains static.
7. Verify enforcement is real—disciplinary actions have been taken for violations, not just documented as a theoretical process.
8. Confirm the 60-day overpayment return obligation is operationalized with a tracking mechanism.

Quality Audit

• All seven OIG compliance program elements assessed with documented evidence
• Compliance officer independence verified (not subordinate to conflicting functions)
• Training program includes both general and role-specific specialized content
• Reporting mechanism is confidential, anonymous, and actively publicized
• Annual audit work plan is risk-based and aligned with compliance risk assessment
• Disciplinary guidelines are uniformly enforced at all organizational levels
• Corrective action process includes root cause analysis and effectiveness monitoring
• Excluded party screening is monthly for all required categories
• Board/leadership reporting is at least quarterly with documented engagement
• Program effectiveness metrics are established and tracked
• 60-day overpayment return obligation is operationalized

Guidelines

• An effective compliance program is not a document—it is an operational system. OIG and DOJ evaluate programs based on whether they function in practice, not whether the policies exist on a shelf.
• The compliance officer must have genuine independence and authority. Subordinating the compliance function to legal, finance, or operations creates structural conflicts that OIG has specifically criticized.
• Training must be risk-specific and role-appropriate. Generic annual compliance training without tailored content for high-risk roles (coders, billers, physician liaisons) is insufficient.
• The 60-day overpayment return clock starts when an overpayment is "identified"—which OIG/CMS interpret as when the organization has or should have through reasonable diligence identified the overpayment. Delaying investigation to delay the clock creates additional FCA liability.
• Compliance programs must evolve with the organization's risk profile. Expansion into new service lines, participation in value-based models, adoption of AI tools, and telehealth expansion all create new compliance risk areas that the program must address.
• OIG has indicated that a compliance program that exists but fails to detect a violation that it should have caught may be treated as ineffective—the program must not only exist but must demonstrably function.
• Always document the program's limitations and areas for improvement—perfection is not required, but continuous improvement must be demonstrated.
• This skill produces compliance program assessment output, not legal advice. All compliance program decisions should involve qualified healthcare compliance counsel.